STOP-CA (Statins TO Prevent the Cardiotoxicity From Anthracyclines)

Study Overview

This research study will test whether atorvastatin, a drug commonly prescribed for reducing cholesterol levels, can protect the heart during chemotherapy with doxorubicin. Atorvastatin is from a family of medications that are commonly called statins

Study Description

STOP-CA: Statins TO Prevent the Cardiotoxicity from Anthracyclines

  • ClinicalTrials.gov Identifier: NCT02943590
  • Protocol Number: 16-440
  • Principal Investigator: Aarti Asnani

Recruitment Status

Open

Contact the research team to learn more about this study.

Fields marked with asterisk (*) are required

Please verify that you are not a bot.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

If you need assistance finding a study or if you have any questions, call us at 617-667-7000